Naphthalene anti-psoriatic agents
AssigneeSyntex (U.S.A.) Inc.
InventorMichael C. Venuti
Life of this patent
Estimating the term…
Loading patent…
AssigneeSyntex (U.S.A.) Inc.
InventorMichael C. Venuti
Estimating the term…
Psoriasis in mammals is relieved by topically administering naphthalenes of the formula: ##STR1## wherein: R.sup.1 is lower alkoxy or optionally substituted phenoxy, R.sup.2 is the same as R.sup.1, or R.sup.2 is hydrogen, lower alkyl, optionally substituted phenyl or optionally substituted phenylalkyl, R.sup.3 is hydrogen, lower alkyl, lower alkoxy, halo, optionally substituted phenyl, optionally substituted phenyl-lower-alkyl or optionally substituted phenyl-lower-alkoxy, and m is 1 or 2; X is the same and is either --C(O)OR.sup.4 or --C(O)NR.sup.5 R.sup.6, wherein R.sup.4 is alkyl, phenyl or benzyl optionally substituted with one or two lower alkyl groups, lower alkoxy groups or halo; and R.sup.5 and R.sup.6 are independently hydrogen, lower alkyl, cycloalkyl or phenyl optionally substituted with one or two lower alkyl groups, lower alkoxy groups or halo.
A compound of the formula ##STR13## wherein:
A composition in a form suitable for topical administration for treating the condition of psoriasis which composition comprises a pharmaceutically acceptable, non-toxic carrier and a psoriasis relieving amount of a compound of the formula ##STR14## wherein:
A method of treating psoriasis in mammals which comprises applying an effective amount of a compound of the formula ##STR15## wherein:
Dependencies are inferred from the claim text.